Clinical trial
Tailored Strategy for Residual Platelet Activity In Advanced Peripheral Artery Disease: New Optimal Management.
NCT01627431 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tailored Strategy for Residual Platelet Activity In Advanced Peripheral Artery Disease: New Optimal Management.
- Lead sponsor
- University of Roma La Sapienza
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- July 31, 2012
- Completion date
- July 31, 2015
- Enrollment
- 410 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.